A Targeted Approach
IMSTAR developed the unique Pathfinder™ technology allowing optimized multimodal scanning, cell detection & analysis, to assist researchers, biologist & pathologist experts. The automated biomarkers multiplex characterization provides accurate quantitative results facilitating the expert’s read-out while increasing the workflow throughput for:
Precision medicine in Oncology by assistance to early diagnostic, prognosis and treatment management.
Identification / recognition by characterization of tumor cells and/or lymphocytes for classification and counting for patient post-therapy follow-up.
Preventive medicine and Biomonitoring of health status of population at risk (pathologies, aging, environmental…).
Pathfinder™ Reader-Analyzer integration in a laboratory
ACCURACY
Improved when compared to visual scoring / interpretation
VERSATILITY
One single system applies to numerous cellular test
COST EFFECTIVE
Automated workflow provides a robust and cost-effective answer to many routine tests
Technology excellence
“Since 2000, IMSTAR continuously developed the next generation of analytical systems for cell characterization and detection. Over 1000 Pathfinder™ systems are installed worldwide. It is now the right time for IMSTAR to partner with key players in this fast expanding market.”
Françoise Soussaline, President & CSO